Navigation Links
Alexza Pharmaceuticals to Present at the Lazard Capital Markets 8th Annual Healthcare Conference
Date:11/2/2011

ted the ADASUVE NDA in December 2009.  In October 2010, the Company received a Complete Response Letter from the FDA regarding the application.  The Company completed an end-of-review meeting with the FDA in December 2010 and a Risk Evaluation and Mitigation Strategy (REMS) guidance meeting with the FDA in April 2011.  The ADASUVE NDA was resubmitted on August 4, 2011 and has a Prescription Drug User Fee Act (PDUFA) goal date of February 4, 2012.  The ADASUVE NDA will be presented to an advisory committee on December 12, 2011.

In October 2011, the Company established a commercial partnership for ADASUVE with Grupo Ferrer International, S.A.  Grupo Ferrer is a leading pharmaceutical company in Europe with extensive operations in the Americas, and is Alexza's partner in the commercialization of ADASUVE in Europe, Latin America, Russia and the Commonwealth of Independent States countries.  Alexza filed its ADASUVE Marketing Authorization Application (MAA) with the European Medicines Agency (EMA) in October 2011.  

For more information about Alexza, the Staccato system technology or the Company's development programs, please visit www.alexza.com.

Safe Harbor Statement

The anticipated presentation will contain forward-looking statements that involve significant risks and uncertainties. Any statement describing the Company's expectations or beliefs is a forward-looking statement, as defined in the Private Securities Litigation Reform Act of 1995, and should be considered an at-risk statement. Such statements are subject to certain risks and uncertainties, particularly those inherent in the process of developing and commercializing drugs, including the adequacy of the Company's capital to support the Company's operations, the potential of the Company's ADASUVE NDA resubmission to adequately address the issues in the Complete Response Le
'/>"/>

SOURCE Alexza Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Alexza to Announce 2011 Third Quarter Financial Results on Monday, November 7, 2011
2. Alexza Announces the Adasuve™ (Staccato® Loxapine) PDAC Meeting Date of December 12, 2011
3. Alexza Pharmaceuticals to Present at the 18th Annual NewsMakers in the Biotech Industry Conference
4. Alexza and Grupo Ferrer Establish Partnership for the Commercialization of Adasuve™ (Staccato® Loxapine) in Europe and Latin America
5. Alexza Pharmaceuticals to Present at the Sixth Annual JMP Securities Healthcare Conference
6. Alexza Announces Adasuve™ (Staccato® Loxapine) PDUFA Goal Date of February 4, 2012
7. Alexza Announces Resubmission of AZ-004 (Staccato® Loxapine) NDA
8. Alexza to Announce 2011 Second Quarter Financial Results on Monday, August 8, 2011
9. Alexza Reports 2011 First Quarter Financial Results and Provides Business Update
10. Alexza to Present at the MDB Bright Lights Conference 2011
11. Alexza Prices $16.1 Million Registered Direct Offering
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/2/2014)... WOONSOCKET, R.I. , Oct. 2, 2014  MinuteClinic, the largest ... the United States , has opened its first walk-in clinics ... two CVS/pharmacy stores in Corpus Christi and ... Corpus Christi in December. The ... new clinics nationwide in 2014. With the Corpus Christi ...
(Date:10/2/2014)... , Oct. 2, 2014  Isis Pharmaceuticals, ... following webcast:What: , Webcast and conference call to ... 2 clinical studies of ISIS-SMN Rx in ... which will be presented on the morning (CEST) ... World Muscle Society in Berlin, GermanyWhen:Friday, October 10 ...
(Date:10/2/2014)... Oct. 1, 2014 The global high content ... by the ,Threat of Obsolescence, wherein technologies as well ... Pharmaceutical and biotechnology companies as well as academic and ... screening as a powerful research tool in drug discovery. ... segment in the high content screening market. In high ...
Breaking Medicine Technology:First MinuteClinic Walk-in Medical Clinics Open in Corpus Christi 2First MinuteClinic Walk-in Medical Clinics Open in Corpus Christi 3Isis Pharmaceuticals to Host Webcast to Discuss ISIS-SMN Rx Results Presented at the World Muscle Society Congress 2High Content Screening Market by Instruments (Cell Imaging and Analysis System), by Applications (Primary and Secondary Screening, Target Identification and Validation, Toxicity Studies, Compound Profiling), Software & Services - Global Forecasts to 2High Content Screening Market by Instruments (Cell Imaging and Analysis System), by Applications (Primary and Secondary Screening, Target Identification and Validation, Toxicity Studies, Compound Profiling), Software & Services - Global Forecasts to 3
... TUMWATER, Wash., Dec. 13, 2011  The Washington Health Care ... COMS Interactive , LLC (COMS or Clinical ... is in alignment with WHCA,s stated objective, which is ... provide long-term health care residents with the highest quality ...
... 2011 IsZo Capital Management LP, one of the largest ... TAROF ), announced today that it delivered the following ... it withdraw immediately from the agenda for the upcoming annual ... December 13, 2011 Board of Directors of Taro ...
Cached Medicine Technology:WHCA Selects COMS Interactive as Affinity Partner 2WHCA Selects COMS Interactive as Affinity Partner 3IzSo Capital Writes to Taro Pharmaceutical Board Demanding that Liability Protection Management Proposals be Removed Immediately from Agenda for Annual Shareholders' Meeting 2IzSo Capital Writes to Taro Pharmaceutical Board Demanding that Liability Protection Management Proposals be Removed Immediately from Agenda for Annual Shareholders' Meeting 3IzSo Capital Writes to Taro Pharmaceutical Board Demanding that Liability Protection Management Proposals be Removed Immediately from Agenda for Annual Shareholders' Meeting 4IzSo Capital Writes to Taro Pharmaceutical Board Demanding that Liability Protection Management Proposals be Removed Immediately from Agenda for Annual Shareholders' Meeting 5
(Date:10/2/2014)... 2014 Robins & Morton received ... Builders and Contractors (ABC) of Alabama. , ABC ... held at Sheraton Birmingham Hotel., , ... Million to $25 Million, Obelisk Award (First Place) ... Government $10 Million to $25 Million, Obelisk Award ...
(Date:10/2/2014)... Amy Norton HealthDay Reporter ... girls free birth control -- especially long-acting implanted devices -- ... current U.S. average, new findings suggest. In a study ... contraceptives substantially cut the girls, rates of unplanned pregnancy and ... per 1,000 girls -- versus a rate of 158 per ...
(Date:10/2/2014)... 1, 2014 (HealthDay News) -- Children with autism are ... fully capable of being more active, a small study ... of 29 children, some with autism and some without. ... of moderate physical activity and 70 more minutes each ... children with autism scored lower on strength, but had ...
(Date:10/2/2014)... Dennis Thompson HealthDay Reporter ... Hospitals that pull out all the stops to rescue ... lives, but the cost of such heroism is questionable, ... about 5 percent better at saving elderly patients with ... operate with less intensity, said senior author Dr. Amir ...
(Date:10/1/2014)... associated with Alzheimer,s disease; however, researchers are still looking ... agent of the onset and development of the disease. ... is not harmful when found in isolation but only ... form the so-called amyloid fibrils , "We are not ... multiple ones because each aggregate of peptide, which can ...
Breaking Medicine News(10 mins):Health News:Robins & Morton wins nine awards from Associated Builders and Contractors 2Health News:Free, Long-Acting Contraceptives May Greatly Reduce Teen Pregnancy Rate 2Health News:Free, Long-Acting Contraceptives May Greatly Reduce Teen Pregnancy Rate 3Health News:Free, Long-Acting Contraceptives May Greatly Reduce Teen Pregnancy Rate 4Health News:Kids With Autism Tend to Be Less Active, Study Says 2Health News:'High-Intensity' Hospitals Save More Elderly After Surgery: Study 2Health News:'High-Intensity' Hospitals Save More Elderly After Surgery: Study 3Health News:Laying siege to beta-amyloid, the key protein in Alzheimer's disease 2
... Persons treated with Interferon (IFN)to treat chronic hepatitis C ... phase itself//. Retinopathy can develop within two weeks from commencement ... in the journal Investigative Ophthalmology & Visual Science (IOVS)in the ... in Japan gauged the changes in diameter of ...
... more daughters and no sons, may have a greater risk ... team of Israeli researchers compared families of men diagnosed with ... daughters and risk of prostate cancer were related. ... may be a link but the factors responsible for prostate ...
... a little gadget that can be used for 15 minutes ... device, developed by New York based company Helicor, is under ... users to lower their own heartbeat by regulated deep breathing, ... device, also on trial for several other conditions including anxiety ...
... in maintaining weight and a healthy lifestyle. On the same ... and diuretics are superfluous with no proven benefits. , ... alcohol as a temporary measure to freshen up the kidneys ... to pump the body with more antioxidants. Drinking lots of ...
... a premature baby is up for women who have ... eliminate precancerous cells, called LEEP or loop// incision, researchers ... a study involving 5000 women, researchers said that nearly ... incision was avoided. Babies born prematurely are seen battling ...
... girls might want to have another look at that ... to recent studies, teenage girls who read articles on ... prone to resort to drastic weight reducing techniques such ... who don’t. ,The study, published in Pediatrics' January ...
Cached Medicine News:Health News:Gender Of Children May Be Linked To Risk Of Prostate Cancer 2Health News:Drop That Glossy, Girl! 2
Straight shafts with 1 x 2 teeth. Serrated handle, non-magnetic and polished finish....
Straight shafts with pointed 4.5 mm tying surfaces. Scalloped wide handle with dull finish....
Straight shafts with 0.5 mm teeth and 6 mm tying platform. Wide serrated handle with thumb catch lock and polished finish....
Angled 45 degree shafts 8 mm long with 1 x 2 teeth and 5 mm tying platform. Serrated handle with dull finish....
Medicine Products: